205.250USD+205.250After-hours (ET)
27.19BMarket Cap
50.28P/E TTM
Alnylam Pharmaceuticals Inc
ALNY Balance Sheet
You can check out the annual or quarterly balance sheets of Alnylam Pharmaceuticals Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing ALNY stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Alnylam Pharmaceuticals Inc Have?
In its most recent quarterly, Alnylam Pharmaceuticals Inc had 1.71B in cash and cash equivalents.
How Much Are Alnylam Pharmaceuticals Inc's Total Liabilities?
Alnylam Pharmaceuticals Inc reported 4.18B in total liabilities as of the latest reported quarter, including 1.47B in current liabilities and 2.71B in non-current liabilities.
What Are Alnylam Pharmaceuticals Inc's Total Assets?
As of the latest reported quarter, Alnylam Pharmaceuticals Inc's total assets were 4.97B, consisting of 4.05B in current assets and 915.67M in non-current assets.
How Much Shareholders' Equity Does Alnylam Pharmaceuticals Inc Have?
Alnylam Pharmaceuticals Inc reported 789.18M in total shareholders' equity as of the latest reported quarter.